12.3.2012
•
News
KSB’s Quarterly X Lege, Issue No. 1/2012
The first 2012 issue of KSB’s quarterly newsletter features articles on the New Transparency Act, the new law supporting alternative energy sources, and the issue of re-exporting pharmaceuticals, which has become a hot topic in the industry. X Lege also continues to summarize the most important changes to be introduced on corporations since 2014 as a result of the recodification of the Czech civil and commercial law, this time focusing on joint-stock companies. Executives and company body members, namely those who receive remuneration for performing their office, may find it interesting to read about the new changes affecting the mandatory pension, sickness, and health insurance schemes.

Other articles
1.4.2025
•
News
We Succeeded in Another International Ranking
Just a week after the results of the Chambers Europe ranking were announced, we’re thrilled to share more great news – the renowned Legal 500 has published its annual overview of the leading law firms in the EMEA region, and we have once again confirmed our strong market position.
26.3.2025
•
News
We Confirmed Our Strong Standing in the Chambers Europe Rankings
We are pleased to announce that we have confirmed last year’s strongest-ever results in the Chambers Europe rankings, published by Chambers & Partners. In the 2025 edition, KŠB once again received excellent rankings in 11 categories. In addition, 13 of our colleagues received individual recognition—our best result in the firm’s history. This year’s recognition is crowned by a nomination for the prestigious Chambers Europe Awards 2025 for the best law firm in the Czech Republic.
5.3.2025
•
News
First Commentary on the Bonds Act Published
C.H. Beck has released the first-ever commentary on the Bonds Act, authored primarily by KŠB’s Jan Lasák, Jan Dědič, and Josef Kříž. Spanning over 700 pages, this comprehensive publication provides an in-depth interpretation of the Act’s individual provisions, drawing on the authors’ extensive expertise in corporate finance